EVX VENTURES_FINAL2.png
  • HOME

  • TEAM

  • PORTFOLIO

  • MORPHOSIS

  • PLATINUM

    • A*STAR
    • JCTeD
  • NEXUS

  • NEWS

  • CAREERS

  • CONTACT

  • More

    Use tab to navigate through the menu items.
    • Sep 27, 2020

    Carmine Therapeutics named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2020

    Carmine Therapeutics has been named as one of FierceBiotech’s “Fierce 15” Biotech companies of 2020, designating it as one of the most promi
    • Jun 30, 2020

    Carmine Therapeutics & Takeda Collaborate to Develop Novel Non-viral Gene Therapies

    Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular...
    • Dec 10, 2019

    Carmine Therapeutics won the Bristol-Myers Squibb’s 2019 Golden Ticket

    Carmine Therapeutics is proud to announce that it has won the Bristol-Myers Squibb’s 2019 Golden Ticket for LabCentral. LabCentral is an...
    • Aug 30, 2019

    Esco Ventures Announces the Launch of Carmine Therapeutics

    30 August 2019 – Esco Ventures is pleased to announce the launch of Carmine Therapeutics and Carmine Therapeutics plans to establish a...
    • HOME

    • TEAM

    • PORTFOLIO

    • MORPHOSIS

    • PLATINUM

      • A*STAR
      • JCTeD
    • NEXUS

    • NEWS

    • CAREERS

    • CONTACT

    • More

      Use tab to navigate through the menu items.
      VENTURES X_EVX_INTL LOGO-FINAL-WHITE.png
      • LinkedIn - White Circle
      info@evx.ventures

      SINGAPORE

      3 Biopolis Drive

      Synapse, #06-11/12/13

      Singapore 138623

      UNITED STATES

      Cambridge Innovation Center

      One Broadway, Kendall Square

      Cambridge MA 02142

      CHINA

      SHANGHAI

      Floor 4-5, Lane 388, Shengrong Road, Pudong New District,

      Shanghai, China

      BEIJING

      Biotech Innovation Works

      No.29 Life Park Road

      Room 202-010, Block D

      Changping District, Beijing, China, 102206

      © 2021 by EVX Ventures Pte. Ltd.